Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Active not recruiting 3Unknown 2Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 1001Lung Neoplasms 759Small Cell Lung Carcinoma 158Breast Neoplasms 72Neoplasms 68Adenocarcinoma of Lung 68Colorectal Neoplasms 49NSCLC 48Stomach Neoplasms 45Pleural Effusion, Malignant 45Melanoma 45Pancreatic Neoplasms 44Brain Neoplasms 42Mesothelioma, Malignant 41Ovarian Neoplasms 31Neoplasm Metastasis 31Prostatic Neoplasms 30Head and Neck Neoplasms 30Mesothelioma 28Esophageal Neoplasms 26Carcinoma 24Carcinoma, Renal Cell 23Urinary Bladder Neoplasms 22Lung Diseases 22Colonic Neoplasms 22Thoracic Neoplasms 19Thymoma 18Liver Neoplasms 18Carcinoma, Hepatocellular 18Pulmonary Disease, Chronic Obstructive 16

Interventions

Radiotherapy 1Radiosurgery 1Nivolumab 1Cisplatin 1BO-112 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Non-Small Cell Lung Cancer Metastatic × Thoracic × Clear all
NCT05265650 2022-07-19

Noelia

Clinica Universidad de Navarra, Universidad de Navarra

Phase 1/2 Unknown
30 enrolled
Thoracic

Non-Small Cell Lung Cancer Metastatic

NCT04646824 2020-12-02

Almonertinib With Chemotherapy in mEGFR NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown
10 enrolled
Thoracic

Non-Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡